Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma Patients
CLAT
1 other identifier
interventional
550
1 country
3
Brief Summary
Nowadays, the tools available to assess the severity of a polytrauma patient in the pre-hospital setting (vital parameters, shock index, MGAP score, Vittel criteria) have their limitations and are sometimes subjective. To date, there are no objective, practical and reproducible tools for triaging these patients. Venous lactataemia also appears to be predictive of poor outcome in severe trauma. However, there are no studies in the literature on capillary lactataemia, which would indicate the potential severity of a polytrauma patient in the pre-hospital setting. However, it is an easily performed, risk-free assay, the results of which can be obtained rapidly at the scene of the accident. The aim of this project is to confirm that, like venous lactataemia, capillary lactataemia can be useful in the pre-hospital phase for predicting a patient's poor outcome. Incorporating this assay into the assessment of potentially severe polytrauma patients in the pre-hospital phase could improve the predictive value of clinical and contextual data and thus enable better referral and management of these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2025
CompletedFirst Posted
Study publicly available on registry
May 13, 2025
CompletedStudy Start
First participant enrolled
February 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2027
March 30, 2026
March 1, 2026
1.4 years
May 2, 2025
March 25, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
lactemie value H0
dosage of capillary lactemia in mmol/L
at inclusion
lactemie value H6
dosage of capillary lactemia in mmol/L
6 hours
Study Arms (1)
polytrauma patient
OTHERcapillary blood sampling
Interventions
capillary blood sampling during the hospital transfert
Eligibility Criteria
You may qualify if:
- Patient over 18 years of age
- Presenting a potentially serious pre-hospital trauma defined by:
- o A road accident or a fall of more than 2 metres
- Requiring the dispatch of a SMUR 06 team (mobile emergency and resuscitation service)
- And transferred to an emergency facility in the Alpes Maritimes with medical assistance.
- Consent signed (by the patient or a relative) after the event if it is not possible to sign immediately.
- Pregnant women may also take part in the study without any risk to themselves or their child.
You may not qualify if:
- Patients with isolated peripheral limb trauma (wrist, elbow, knee, ankle, shoulder)
- Patients under legal protection (guardianship, curatorship)
- Patients in cardiorespiratory arrest when taken into care by the SMUR (emergency medical services)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Antibes Hospital
Antibes, 06400, France
Cannes hospital
Cannes, 06000, France
Nice University Hospital
Nice, 06000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2025
First Posted
May 13, 2025
Study Start
February 7, 2026
Primary Completion (Estimated)
June 15, 2027
Study Completion (Estimated)
December 15, 2027
Last Updated
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share